Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Elsevier to Work with Heel for Mechanism-based Drug Action Discovery
Posted on January 6th, 2021 by Thea Howe in Pharma R&D
Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, have recently completed a series of research projects with a focus on improving exploratory preclinical studies.
(more…)Insights begin with clean, reusable data
Posted on August 24th, 2020 by Ani Marrs in Pharma R&D
Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this helpful new infographic that demonstrates how Entellect is centered around the importance of reusable data, irrespective of scientific domain.
(more…)The Dawn of a European Health Data Space β Challenges
Posted on July 16th, 2020 by Mark Siebert in Pharma R&D
The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality.
(more…)The Dawn of a European Health Data Space β Opportunities
Posted on July 9th, 2020 by Mark Siebert in Pharma R&D
At the beginning of 2020, the European Commission introduced a βEuropean strategy for data.β The document proposes to bolster and advance the data economy in Europe with a view towards capturing βthe benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and convenient public services.β
(more…)